A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemotherapy

Pediatric Hematology and Oncology

Volumn 17, Issue 6, 2000, Pages 445-455

  White, L ^a   Daly, S A ^b   McKenna, C J ^b   Zhestkova, N ^c   Leal, C ^d   Breatnach, F ^e   Smelhaus, V ^f   Hung, I J ^g   Kowalczyk, J ^h   Ninane, J ⁱ   Mitchell, T ^b   Haigh, C ^b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b GLAXOSMITHKLINE   (United Kingdom)

^c Russian Children's Hospital   (Russian Federation)

^d INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^e OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^f UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^g CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^h Department of Pediatric Hematology and Oncology ^*  (Poland)

ⁱ CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Chemotherapy; Nausea; Ondansetron; Oral syrup; Vomiting

Indexed keywords

ANTINEOPLASTIC AGENT; DEXAMETHASONE; ONDANSETRON;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; RANDOMIZED CONTROLLED TRIAL; SYRUP; VOMITING;

EID: 0033864498     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010050120791     Document Type: Article

References (24)

1. The management of chemotherapy-induced nausea and vomiting in children
2. Chemotherapy-associated nausea and vomiting in pediatric oncology patients
3. Platinum nephrotoxicity
4. Learned taste aversions in children receiving chemotherapy
5. Anticipatory, nausea and vomiting in pediatric cancer patients
6. Metoclopramide dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy
7. Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapy
8. Anti-emetics in children receiving cancer chemotherapy: A double-blind prospective randomized study comparing metoclopramide with chlorpromazine
9. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: A double-blind, crossover trial
10. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy
11. Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukaemia
12. 3 antagonist ondansetron: An effective outpatient anti-emetic in cancer treatment
13. The role of ondansetron in pediatric patients: A review of three studies
14. Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children
15. Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?
16. Prevention of cisplatin-induced emesis: A double-blind multicentre randomized crossover study comparing ondansetron and ondansetron plus dexamethasone
17. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy
18. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis
19. Ondansetron and tropisetron with dexamethasone in the prophylaxis of acute vomiting induced by non-cisplatin-containing chemotherapy
20. Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies
21. Oral ondansetron: An effective ambulatory complement to intravenous ondansetron in the control of chemotherapy-induced nausea and vomiting in children
22. Nausea and vomiting as major complications of cancer chemotherapy
23. Quality of life: Consequences of chemotherapy induced emesis
24. Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer